Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland

BackgroundPersistence with antifibrotic medications in patients with idiopathic pulmonary fibrosis (IPF) is crucial for long-term outcomes. However, real-world data regarding treatment persistence patterns in IPF are scarce.MethodsWe conducted a post hoc analysis of two retrospective, real-world, mu...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Sebastian Majewski, Katarzyna Górska, Katarzyna B. Lewandowska, Magdalena M. Martusewicz-Boros, Małgorzata Sobiecka, Wojciech J. Piotrowski
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2025-06-01
Цуврал:	Frontiers in Pharmacology
Нөхцлүүд:	idiopathic pulmonary fibrosis IPF antifibrotic therapy pirfenidone nintedanib treatment persistence
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1586197/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!